• Save $90 until Aug 21: Register Now for Early Bird Savings!
    38th Annual GAPNA Conference

    October 3-5, 2019 at the Paris Hotel, Las Vegas, NV.

    Focused education; lasting connections, networking, free access to the GAPNA Online Library.

    Earn up to 22 contact hours (including pre-conference workshops).

    Get more information and register now!

  • 2019 Senior Report Senior Report: Older Americans have more options for home care, but still struggling.

    The United Health Foundation has released results of a sweeping new study benchmarking the health of older adults. The America's Health Rankings® Senior Report was created in partnership with GAPNA to improve the health of America's seniors.

    The data will help advanced practice nurses and other providers deliver quality care.

    Find out about it!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • FREE continuing education credit is available for the following session:

    "Decisional Capacity"

    (session captured at the GAPNA 2018 Annual Conference)

    For July/August 2019 - Get Your Free CNE Now!

Most Nursing Home Residents with Advanced Dementia Get Medications With Questionable Benefits and Substantial Costs

More than half of nursing home residents with advanced dementia continue to receive medications that may not help them, but incur substantial financial cost.

An analysis of more than 5,400 residents at 460 facilities (using 2009-2010 data) found nearly 54% of residents received at least one medication of questionable benefit.

The average 90-day expenditure for medications with questionable benefits was $816.

This accounts for 35.2% of the total average 90-day medication costs for residents with advanced dementia who were prescribed common medications with questionable benefits.

To learn more, see Tjia et al. (2014). Use of medications of questionable benefit in advanced dementia. JAMA Internal Medicine, 174(11), 1763-1771.

Related Topic 1: 

GAPNA Newsletter Issue: